- Home
- SSBI vs KZR Comparison
SSBI vs KZR Comparison
Compare SSBI & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBI
- KZR
- Stock Information
- Founded
- SSBI 1982
- KZR 2015
- Country
- SSBI United States
- KZR United States
- Employees
- SSBI N/A
- KZR N/A
- Industry
- SSBI Major Banks
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- SSBI Finance
- KZR Health Care
- Exchange
- SSBI Nasdaq
- KZR Nasdaq
- Market Cap
- SSBI 55.8M
- KZR 65.3M
- IPO Year
- SSBI 2006
- KZR 2018
- Fundamental
- Price
- SSBI $7.30
- KZR $7.62
- Analyst Decision
- SSBI
- KZR Hold
- Analyst Count
- SSBI 0
- KZR 2
- Target Price
- SSBI N/A
- KZR $20.00
- AVG Volume (30 Days)
- SSBI 22.3K
- KZR 72.5K
- Earning Date
- SSBI 10-30-2024
- KZR 11-12-2024
- Dividend Yield
- SSBI 3.79%
- KZR N/A
- EPS Growth
- SSBI N/A
- KZR N/A
- EPS
- SSBI 0.72
- KZR N/A
- Revenue
- SSBI $31,552,000.00
- KZR N/A
- Revenue This Year
- SSBI N/A
- KZR N/A
- Revenue Next Year
- SSBI N/A
- KZR $66.68
- P/E Ratio
- SSBI $10.22
- KZR N/A
- Revenue Growth
- SSBI N/A
- KZR N/A
- 52 Week Low
- SSBI $5.68
- KZR $5.20
- 52 Week High
- SSBI $13.55
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- SSBI 54.14
- KZR 53.01
- Support Level
- SSBI $6.60
- KZR $7.21
- Resistance Level
- SSBI $7.45
- KZR $7.65
- Average True Range (ATR)
- SSBI 0.35
- KZR 0.26
- MACD
- SSBI 0.12
- KZR -0.01
- Stochastic Oscillator
- SSBI 88.55
- KZR 95.71
About SSBI Summit State Bank
Summit State Bank provides various banking products and services to individuals and businesses primarily in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.